Concepedia

F. Bianic

FB

12

Publications

347

Citations

11

H-Index

2011

Active since

Affiliations

Sanofi (France)(Current)

Janssen (Switzerland)

Optum (United States)

University College London

Janssen (United States)

F. Bianic is an author at Sanofi (France) specializing in medicine, epidemiology, and public health.

ORCID

Top concepts

Publications per year

2011–2021

12

Publications

12

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy

Francesco Saverio Mennini, Paolo Bonanni, F. Bianic et al. · Cost Effectiveness and Resource Allocation · 2017 · 52 citations · Full text

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis

J.-Y. Reginster, F. Bianic, Ross Campbell et al. · Osteoporosis International · 2019 · 51 citations · Full text

An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany

Nathalie Largeron, Karl Ulrich Petry, Jorge Jacob et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2016 · 44 citations

Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers

Rima Nabbout, Maya Dirani, Théo Teng et al. · Epilepsy & Behavior · 2020 · 43 citations · Full text

, , +9

Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients

S. Cure, F. Bianic, Sandra Gavart et al. · Journal of Medical Economics · 2013 · 31 citations

Rows per page

1–5 of 12